Page results
-
Colleagues, past and present, came together to mark the tenth anniversary of University College Hospital at Westmoreland Street.
-
London’s Business Design Centre opens its doors this week as a large- scale COVID-19 vaccination facility.
-
A new CAR T-cell therapy developed by scientists at UCL has fewer ‘toxic’ side-effects and is more durable, targeting and killing cancer cells for longer, concludes a Phase 1 clinical trial of patients at UCLH.
-
Acute loss of sense of smell should be considered globally as a criterion for self-isolation, testing, and contact tracing for Covid-19 infection according to researchers at UCLH and UCL.
-
Elderly patients suffering the most common type of heart attack may benefit from more invasive treatment, new research involving UCLH has shown.
-
A pioneering breast cancer therapy developed by UCLH and UCL, which requires just one shot of radiotherapy rather than conventional weeks-long treatment, has proven to be as effective for most women in treating the disease.
-
The street gallery at University College Hospital is home to a new exhibition of artworks presenting unique perspectives on the theme of gardens.
-
Initial results from an early phase study testing the safety and efficacy of a new drug for multiple myeloma have shown a 100 per cent overall response rate in patients with recurrent disease who were given the clinically recommended dose of the investigational drug.
-
This booklet has been written by the Autonomic Unit at The National Hospital for Neurology and Neurosurgery (NHNN). The aim of the booklet is to provide information about the Dynamic Sweat Test (DST).
-
This page is for patients who have been asked to take part in a service evaluation looking at Magnetic Resonance Imaging (MRI) at the Proton Beam Therapy department at UCLH. This information explains why we are doing this evaluation and what it would involve for you.
File results
-
-
-
-
-
-
-
-
FOI/2021/0477 - Data Quality Framework
-
-